expert comment: the adaura results | lecia sequist
Published 4 years ago • 444 plays • Length 5:18Download video MP4
Download video MP3
Similar videos
-
4:56
researcher comment: the adaura trial | roy herbst
-
6:24
highlights of the esmo 2017 lung cancer program | lecia sequist
-
2:34
adaura cns analysis: key messages and future directions | masahiro tsuboi
-
4:49
tatton trial – savolitinib plus osimertinib in egfr-mutated, met-amplified nsclc | lecia sequist
-
0:58
dr. sequist distinguishes osimertinib from earlier nsclc tkis
-
11:20
the oncology brothers discuss adaura trial findings
-
9:08
【おしえて!瀬戸先生⑨】★egfr 耐性後の治療★タグリッソ(オシメルチニブ)後の治療 みんなどうしてる(再アップ)
-
3:01
going from stage iv lung cancer to clean scans
-
3:16
adaura phase iii trial data: practice changing?
-
6:20
asco 2023 highlights on adjuvant osimertinib in resected egfr mutated nsclc: the adaura trial
-
6:23
adaura trial; early stage non–small cell lung cancer
-
0:55
lung cancer at asco 2023: adaura and adcs
-
5:03
adaura results: adjuvant osimertinib for egfrm non-small cell lung cancer
-
1:43
updated results from the caspian trial of durvalumab plus chemo in sclc
-
2:20
adjuvant osimertinib in resected egfrm nsclc: the os data from the adaura trial
-
1:15
lecia sequist, md, mph, highlights lung cancer research at asco 2024
-
1:07
infinity: neoadjuvant or definitive tremelimumab with durvalumab in msi gac/gejac
-
7:31
lecia v. sequist, md, mph: lung cancer genomics
-
1:08
adaura clinical trial update
-
27:03
dr. lecia sequist (pt. 1): combining interests in science and practical issues in cancer care